Rates of Post Intravitreal Anti-VEGF Injection Endophthalmitis: Management Strategies and Visual Acuity Outcomes From the AAO IRIS Registry

Related

• 

  Board-Certified Providers Are Associated With a Reduced Risk of Endophthalmitis After Intravitreal Injections

  Geoffrey G. Emerson, MD, PhD, FASRS

  Updates from the Field

  2021

• 

  Board-Certified Providers Are Associated With a Reduced Risk of Endophthalmitis After Intravitreal Injections

  Geoffrey G. Emerson, MD, PhD, FASRS

  Annual Meeting Talks

  2021

• 

  AMD Neovascular Expert Panel

  Robert L. Avery, MD

  Nizar S Abdelfattah, M.D.

  Nancy M. Holekamp, MD, FASRS

  Peter K. Kaiser, MD FASRS

  Pravin U. Dugel, MD

  Annual Meeting Talks

  2016